These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8638102)

  • 1. T cell inactivation linked to Ras block.
    Williams N
    Science; 1996 Mar; 271(5253):1234. PubMed ID: 8638102
    [No Abstract]   [Full Text] [Related]  

  • 2. Blocked Ras activation in anergic CD4+ T cells.
    Fields PE; Gajewski TF; Fitch FW
    Science; 1996 Mar; 271(5253):1276-8. PubMed ID: 8638108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive active p21ras enhances primary T cell responsiveness to Ca2+ signals without interfering with the induction of clonal anergy.
    Crespi D; Massa S; Basso V; Colombetti S; Mueller DL; Mondino A
    Eur J Immunol; 2002 Sep; 32(9):2500-9. PubMed ID: 12207334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription.
    Zhang J; Salojin KV; Delovitch TL
    Int Immunol; 2001 Mar; 13(3):377-84. PubMed ID: 11222507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.
    Nishina H; Bachmann M; Oliveira-dos-Santos AJ; Kozieradzki I; Fischer KD; Odermatt B; Wakeham A; Shahinian A; Takimoto H; Bernstein A; Mak TW; Woodgett JR; Ohashi PS; Penninger JM
    J Exp Med; 1997 Sep; 186(6):941-53. PubMed ID: 9294148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells.
    Li W; Whaley CD; Mondino A; Mueller DL
    Science; 1996 Mar; 271(5253):1272-6. PubMed ID: 8638107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.
    DeSilva DR; Feeser WS; Tancula EJ; Scherle PA
    J Exp Med; 1996 May; 183(5):2017-23. PubMed ID: 8642312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox regulation of cell signalling.
    Lander HM; Milbank AJ; Tauras JM; Hajjar DP; Hempstead BL; Schwartz GD; Kraemer RT; Mirza UA; Chait BT; Burk SC; Quilliam LA
    Nature; 1996 May; 381(6581):380-1. PubMed ID: 8632794
    [No Abstract]   [Full Text] [Related]  

  • 9. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells.
    Zhang J; Salojin KV; Gao JX; Cameron MJ; Bergerot I; Delovitch TL
    J Immunol; 1999 Apr; 162(7):3819-29. PubMed ID: 10201899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes.
    Genot E; Reif K; Beach S; Kramer I; Cantrell D
    Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells.
    Yi Y; McNerney M; Datta SK
    J Immunol; 2000 Dec; 165(11):6627-34. PubMed ID: 11086108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of p21ras/MAPK signal transduction molecules decreases with age in mitogen-stimulated T cells from rats.
    Pahlavani MA; Harris MD; Richardson A
    Cell Immunol; 1998 Apr; 185(1):39-48. PubMed ID: 9636681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulation with dexamethasone and prostaglandin E2: a novel paradigm for the induction of T-cell anergy.
    Elliott LH; Levay AK
    Cell Immunol; 1997 Sep; 180(2):124-31. PubMed ID: 9341742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells.
    DeSilva DR; Jones EA; Feeser WS; Manos EJ; Scherle PA
    Cell Immunol; 1997 Sep; 180(2):116-23. PubMed ID: 9341741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector pathways regulating T cell activation.
    Favero J; Lafont V
    Biochem Pharmacol; 1998 Dec; 56(12):1539-47. PubMed ID: 9973174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signalling intermediates of CD28.
    Ben-Neriah Y; Alkalay I; Yaron A; Hatzubai A; Jung S
    Res Immunol; 1995; 146(3):154-8. PubMed ID: 8525045
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP; Buckley DJ; Buckley AR
    Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD28 in the activation of T lymphocytes to proliferate in response to IL4.
    Chiodetti L; Schwartz RH
    Res Immunol; 1995; 146(3):169-71. PubMed ID: 8525048
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1.
    Boussiotis VA; Freeman GJ; Berezovskaya A; Barber DL; Nadler LM
    Science; 1997 Oct; 278(5335):124-8. PubMed ID: 9311917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.